Navigation Links
Francesco Granata, M.D. Joins Board of Prismic Pharmaceuticals
Date:12/3/2013

SCOTTSDALE, Ariz., Dec. 3, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based, commercial-stage pharmaceutical company focused on prescription Medical Foods, today announced the election of Francesco Granata, M.D., to its Board of Directors.

Dr. Granata is currently Executive in Residence at Warburg Pincus, a leading private equity firm focused on growth investing.  He is an accomplished healthcare executive with more than 35 years of experience in the international pharmaceutical and biotechnology industries.  Before joining Warburg Pincus, Dr. Granata held senior management positions at Pfizer, where he was President of the Northern Europe region; Schering-Plough, where he served as Group Vice President and President for the Europe and Canada region; and most recently at Biogen Idec Inc., where he was Executive Vice President of Global Commercial Operations, with responsibility for worldwide Commercial Operations and Medical Affairs.  Dr. Granata is also a Board Member of Circassia, a UK-based specialty Biopharmaceutical company and Italfarmaco, one of Italy's leading international pharmaceutical groups. 

"Francesco Granata has had an exceptionally successful career and brings a wealth of healthcare experience and strategic vision to our Board of Directors," commented Peter Moriarty, Chairman and CEO of Prismic.  "Prior to joining the pharmaceutical industry, Francesco practiced as a physician and surgeon, specializing in Cardiology.  He has also been Chairman of the European Committee of the Pharmaceutical Research and Manufacturers Association of America and Co-Chairman of the Heads of Europe Committee of the European Federation of Pharmaceutical Industries and Associations.  We are honored that he has accepted the invitation to join our Board.  We are confident of the contribution he will make in helping the Board to guide Prismic's continuing path to commercial success and increased value for our shareholders."  

"Prismic has an extremely interesting and innovative portfolio of patent-protected products," stated Dr. Granata. "I believe that the company has identified products and market opportunities that are medically important as well as commercially very attractive. Prismic has the choice of exploiting those opportunities alone or in partnership with other commercial entities in the United States and Internationally.  I look forward to working with my fellow Board members to help Management drive optimum value for our shareholders."

About Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc., is a privately held, commercial-stage pharmaceutical company focused on the development and marketing of prescription Medical Foods for the clinical dietary management of the metabolic processes associated with many of the disorders associated with the aging population, particularly where inflammation is involved.  The company, founded in 2011, is headquartered in Scottsdale, Arizona, with offices in Boston, USA, and London, England. Contact 480.422.1810 or visit www.PrismicPharma.com.

INFORMATION CONTACT
Peter Moriarty
Tel: 480.422.1810


'/>"/>
SOURCE Prismic Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
2. Guri Stark Joins CorTechs Labs as CEO
3. Eisai Joins Groundbreaking Tuberculosis Drug Accelerator Partnership to Discover New Tuberculosis Drugs
4. BD Joins National Patient Safety Foundation Corporate Council, Furthers Commitment to Safety
5. Rafarma Pharmaceuticals, Inc. (RAFA) Joins in Economic Development Coalition to Increase Biotech Growth in Terbuny, Russia.
6. Helping New Yorkers Prevent Heart Attacks: Itamar Medical Joins The Fight With New Campaign
7. Bay Alarm Medical Joins The Fight To End Hunger
8. Chris Newmarker joins MPMN and Qmed
9. State Senator Mae Beavers Joins Local Leaders, Retailers, Pharmacists To Launch Anti-Smurfing Public Awareness Campaign
10. Jefferson School of Population Health joins the Alliance for Rational Use of NSAIDs
11. RidgeCrest Herbals New Thyroid Thrive Joins Companys List Of Top 10 Bestsellers In Record Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/11/2017)... 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... Las Piedras, Puerto Rico , where ... Following a comprehensive ... minor structural damage, temporary loss of power and minimal ... completed, manufacturing operations have resumed, and the company expects ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of Eating ... excellence for the field of eating disorders, announces the opening of early registration ... Orlando, Florida at the Omni Resort at ChampionsGate. , The annual ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
Breaking Medicine News(10 mins):